Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Mihm

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Plos One|December 31, 2013
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samplesAhmad Amanzada, Waltraut Kopp, Ulrich Spengler, et al.
Journal of Medical Virology|November 19, 2002
Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infectionVolker Meier, Erik Bürger, Sabine Mihm, et al.
Plos One|November 26, 2015
Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis CAhmad Amanzada, Lars Reinhardt, Dorothea Fey, et al.
BMC Research Notes|June 26, 2015
Association of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective studyNicolae-Catalin Mechie, Armin D Goralzcyk, Lars Reinhardt, et al.
World Journal of Gastroenterology|November 8, 2005
Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patientsPerdita Wietzke-Braun, Volker Meier, Katrin Neubauer-Saile, et al.
BMC Infectious Diseases|September 18, 2014
Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapyAhmad Amanzada, Armin D Goralczyk, Lars Reinhardt, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 27, 2009
Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activityJasmin Mertens, Rusudan Bregadze, Ashham Mansur, et al.
Journal of Medical Virology|May 29, 2009
TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis CEva Askar, Rusudan Bregadze, Jasmin Mertens, et al.
World Journal of Gastroenterology|August 19, 2007
Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlatesPerdita Wietzke-Braun, Larissa-Bettina Manhardt, Albert Rosenberger, et al.
European Journal of Gastroenterology & Hepatology|August 9, 2006
Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infectionPerdita Wietzke-Braun, Adil B Maouzi, Larissa B Mänhardt, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Plos One|December 31, 2013
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samplesAhmad Amanzada, Waltraut Kopp, Ulrich Spengler, et al.
Journal of Medical Virology|November 19, 2002
Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infectionVolker Meier, Erik Bürger, Sabine Mihm, et al.
Plos One|November 26, 2015
Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis CAhmad Amanzada, Lars Reinhardt, Dorothea Fey, et al.
BMC Research Notes|June 26, 2015
Association of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective studyNicolae-Catalin Mechie, Armin D Goralzcyk, Lars Reinhardt, et al.
World Journal of Gastroenterology|November 8, 2005
Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patientsPerdita Wietzke-Braun, Volker Meier, Katrin Neubauer-Saile, et al.
BMC Infectious Diseases|September 18, 2014
Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapyAhmad Amanzada, Armin D Goralczyk, Lars Reinhardt, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 27, 2009
Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activityJasmin Mertens, Rusudan Bregadze, Ashham Mansur, et al.
Journal of Medical Virology|May 29, 2009
TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis CEva Askar, Rusudan Bregadze, Jasmin Mertens, et al.
World Journal of Gastroenterology|August 19, 2007
Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlatesPerdita Wietzke-Braun, Larissa-Bettina Manhardt, Albert Rosenberger, et al.
European Journal of Gastroenterology & Hepatology|August 9, 2006
Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infectionPerdita Wietzke-Braun, Adil B Maouzi, Larissa B Mänhardt, et al.
Pageof 3